Abstract
The need to screen the kinetic characteristics of pharmaceuticals in early development stages is justified. The advantages and limitations of cassette dosing in pharmacokinetic investigations are discussed. The dose and the presence or absence of pharmaceutical interactions are shown to be the critical factors affecting the reliability of pharmacokinetic parameters assessed by the cassette method. The hypothesis that toxicokinetic cassette screening of compounds capable of interacting is appropriate for describing the slow elimination phase was verified by comparing lewisite excretion parameters after injection into laboratory animals of lewisite and a mustard-gas—lewisite mixture.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
